204 related articles for article (PubMed ID: 30057407)
1. Tumour-stroma ratio and prognosis in gastric adenocarcinoma.
Kemi N; Eskuri M; Herva A; Leppänen J; Huhta H; Helminen O; Saarnio J; Karttunen TJ; Kauppila JH
Br J Cancer; 2018 Aug; 119(4):435-439. PubMed ID: 30057407
[TBL] [Abstract][Full Text] [Related]
2. Histological assessment of stromal maturity as a prognostic factor in surgically treated gastric adenocarcinoma.
Kemi NA; Eskuri M; Pohjanen VM; Karttunen TJ; Kauppila JH
Histopathology; 2019 Dec; 75(6):882-889. PubMed ID: 31173384
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
[TBL] [Abstract][Full Text] [Related]
4. Tumor Budding and Prognosis in Gastric Adenocarcinoma.
Kemi N; Eskuri M; Ikäläinen J; Karttunen TJ; Kauppila JH
Am J Surg Pathol; 2019 Feb; 43(2):229-234. PubMed ID: 30334831
[TBL] [Abstract][Full Text] [Related]
5. Tumour-stroma ratio and 5-year mortality in gastric adenocarcinoma: a systematic review and meta-analysis.
Kemi N; Eskuri M; Kauppila JH
Sci Rep; 2019 Nov; 9(1):16018. PubMed ID: 31690815
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiology of the two types of gastric adenocarcinoma in Iceland according to the Laurén histological classification 1990-2009].
Olafsdottir HS; Alexiusdottir KK; Lund SH; Jonasson JG; Jonsson T; Skuladottir H
Laeknabladid; 2016 Mar; 102(3):125-30. PubMed ID: 26985590
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Stroma Ratio is an independent predictor for overall survival and disease free survival in gastric cancer patients.
Aurello P; Berardi G; Giulitti D; Palumbo A; Tierno SM; Nigri G; D'Angelo F; Pilozzi E; Ramacciato G
Surgeon; 2017 Dec; 15(6):329-335. PubMed ID: 28629870
[TBL] [Abstract][Full Text] [Related]
8. Tumour budding and tumour-stroma ratio in hepatocellular carcinoma.
Kairaluoma V; Kemi N; Pohjanen VM; Saarnio J; Helminen O
Br J Cancer; 2020 Jul; 123(1):38-45. PubMed ID: 32362654
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
[TBL] [Abstract][Full Text] [Related]
10. Prognostic evaluation of tumor-stroma ratio in patients with early stage cervical adenocarcinoma treated by surgery.
Pongsuvareeyakul T; Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Intaraphet S; Siriaunkgul S
Asian Pac J Cancer Prev; 2015; 16(10):4363-8. PubMed ID: 26028100
[TBL] [Abstract][Full Text] [Related]
11. Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients.
Zengin M
Pathol Res Pract; 2019 Nov; 215(11):152635. PubMed ID: 31564570
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
[TBL] [Abstract][Full Text] [Related]
14. Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma.
Borch K; Jönsson B; Tarpila E; Franzén T; Berglund J; Kullman E; Franzén L
Br J Surg; 2000 May; 87(5):618-26. PubMed ID: 10792320
[TBL] [Abstract][Full Text] [Related]
15. The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy?
Courrech Staal EF; Wouters MW; van Sandick JW; Takkenberg MM; Smit VT; Junggeburt JM; Spitzer-Naaykens JM; Karsten T; Hartgrink HH; Mesker WE; Tollenaar RA
Eur J Cancer; 2010 Mar; 46(4):720-8. PubMed ID: 20044247
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content - a short report.
Sandberg TP; Sweere I; van Pelt GW; Putter H; Vermeulen L; Kuppen PJ; Tollenaar RAEM; Mesker WE
Cell Oncol (Dordr); 2019 Jun; 42(3):397-403. PubMed ID: 30847807
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
19. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.
Chang KK; Cho SJ; Yoon C; Lee JH; Park DJ; Yoon SS
Ann Surg Oncol; 2016 Dec; 23(13):4238-4246. PubMed ID: 27364501
[TBL] [Abstract][Full Text] [Related]
20. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation.
Lv Z; Cai X; Weng X; Xiao H; Du C; Cheng J; Zhou L; Xie H; Sun K; Wu J; Zheng S
Surgery; 2015 Jul; 158(1):142-50. PubMed ID: 25890776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
